Pharmaceutical composition using liensinine to work in coordination with paclitaxel for chemotherapy and application method of pharmaceutical composition

An application method and technology of chemotherapeutic drugs, applied in drug combinations, pharmaceutical formulations, anti-tumor drugs, etc., can solve the problem of few drug combinations

Inactive Publication Date: 2015-05-06
ARMY MEDICAL UNIV
View PDF0 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the drug combination itself cannot completely eliminate the problem of drug resistance, so people have been working hard to find more different drug

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Pharmaceutical composition using liensinine to work in coordination with paclitaxel for chemotherapy and application method of pharmaceutical composition
  • Pharmaceutical composition using liensinine to work in coordination with paclitaxel for chemotherapy and application method of pharmaceutical composition
  • Pharmaceutical composition using liensinine to work in coordination with paclitaxel for chemotherapy and application method of pharmaceutical composition

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0021] 1. A drug combination using liensinine in conjunction with paclitaxel for chemotherapy. The drug combination consists of liensinine injection and chemotherapy drug paclitaxel injection.

[0022] After knowing that the drug combination provided by the present invention can improve curative effect and reduce adverse reactions, when using the drug combination of the present invention to avoid drug resistance or drug resistance, those skilled in the art are fully capable of targeting specific malignant For tumors, the ratio between the two components of Lianxinine Injection and Paclitaxel Injection has been determined only through limited routine tests. For the several malignant tumor cells selected when the present invention is doing experimental verification, it is advisable that the drug combination adopts such a proportioning, the actual drug dose in the liensinine injection: the actual drug dose in the paclitaxel injection=4.88mg : 0.122 mg.

[0023] Two, an applicati...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a pharmaceutical composition using liensinine to work in coordination with paclitaxel for chemotherapy and an application method of the pharmaceutical composition. The pharmaceutical composition comprises a liensinine injection solution and a chemotherapy drug paclitaxel injection solution. The application method comprises the following steps: (1) performing intravenous injection of liensinine once daily according to the dose that actual dosage in the liensinine injection solution to the body weight of a patient is equal to 4.88mg/kg; (2) performing intravenous injection of paclitaxel once according to the dose that the actual dosage in the paclitaxel injection solution to the body weight of the patient is equal to 2.562mg/kg on the day of injecting liensinine according to the step (1); (3) performing intravenous injection of the paclitaxel injection solution once again according to the dose in the step (2) on the twenty-second day; and (4) determining whether to circulate according to the method of the steps (1)-(3) or not, the number of circulation times and the intermediate drug withdrawal time from the forty-third day according to the bearing capacity and the treatment effect of a patient body. Compared with the prior art, in the aspect of inhibiting and killing various malignant tumor cells, the pharmaceutical composition provided by the invention has the advantages of reducing the dosage, shortening the treatment period and reducing the occurrence of toxic and side reactions.

Description

technical field [0001] The present invention relates to the drug combination and specific application method of using other drugs in cooperation with paclitaxel when treating malignant tumors with chemotherapy. Background technique [0002] Chemotherapy is one of the methods for treating malignant tumors (cancer). It uses chemical drugs to prevent the proliferation, invasion, and metastasis of cancer cells, and finally kills cancer cells. Paclitaxel, also known as Paclitaxel, is one of the chemotherapy drugs used in clinical practice, and its structural formula is: [0003] [0004] Paclitaxel injection (also known as "injection" or "injection") is used clinically. It is mainly used in the chemotherapy of ovarian cancer and breast cancer, and also has a certain effect on lung cancer, colorectal cancer, melanoma, head and neck cancer, lymphoma and brain tumor. However, paclitaxel, like other chemotherapeutic drugs, due to its poor selectivity to tumor cells, will inevita...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K31/4725A61P35/00A61P35/02A61K31/337
Inventor 高宁周静李国兵张宏伟
Owner ARMY MEDICAL UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products